Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Climbs 1.62% to USD 227.66
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Climbs 1.62% to USD 227.66 Kalkine India
Covered in this story
Call it yourself
No calls on $ALNY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alnylam Pharmaceuticals →Dalsna Finance is currently tracking 48 stories mentioning Alnylam Pharmaceuticals, the earliest published 10 Jun 2026.
Summary aggregated from Kalkine India's public RSS feed. The full reporting belongs to Kalkine India — please read it on their site.